Simpatie Logo Simpatie: Safety Improvement for Patients in Europe Logo of the European Union




- Login

Table 30 'Electronic Trigger Tool - Surveillance of Adverse Drug Events'

  • Please find a pdf-file of Table 30 here






  • PSI 29: Electronic Trigger Tool - Surveillance of Adverse Drug Events
    Origin: PSI by SimPatIE
    Dimension Description
    Description of Specific
    Aspects of Patient Safety
    Adverse drug events (ADEs) are continually placing patients at
    risk of harm. ADEs are the single most frequent adverse event
    type. Tracking the occurrences of ADEs over time is a useful way
    to tell about the development of safety related to medication.
    Thus use of specified "triggers" or clues – signalising that an ADE
    might have occurred – is a suitable patient safety measure.
    Aim of the PSI This PSI is intended to flag rates of ADEs.
    Level of Determination of
    Patient Safety
    Safety is assessed at the aggregated patient level.
    Source(s) Manual chart review has been considered the "gold-standard" for
    identifying adverse events in many patient safety studies. The
    methodology is expensive and has shown imperfect (46).
    Automated surveillance for adverse drug events has been
    demonstrated firstly by Classen et al. in the early 1990s (47).
    Since then more groups have developed electronic methods
    suitable for detecting adverse events based on the use of
    "triggers", coded data, free-text clinical narratives, or a
    combination of techniques (47-53). Advances in such electronic
    systems will facilitate our ability to monitor adverse events (46).
    Thus this PSI is based upon a computerised screening tool that
    searches free-text discharge summaries for trigger words
    representing possible adverse drug events.
    Extent of Clinically Testing To assess the accuracy and define the epidemiology of computer
    based medication error reports a retrospective cohort study of 581
    error reports containing 1010 medication errors was conducted.
    Of medication errors reviewed, 298 (30%) were prescribing
    errors, 245 (24%) were dispensing errors, 410 (41%) were
    administration errors, and 57 (6%) involved medication
    administration records (MAR). Following expert review the
    overall distribution of error type categories did not change
    significantly, although only MAR errors were underreported by
    the reporters. The researchers concluded “despite clear
    imperfections in the data captured, medication error reporting
    tools are effective as a means of collecting reliable information on
    errors rapidly and in real time. Our data suggest that
    administration errors are at least as common as prescribing errors
    in children” (49).
    A recent study by Murff et al. of the development of an electronic
    trigger tool was based on a cohort study including 424 randomly
    selected admissions. All discharge summaries with a trigger word
    SImPatIE WP4 – Catalogue of Patients Safety Indicators
    77
    present underwent chart review by two independent physician
    reviewers. The presence of adverse events was assessed using
    structured implicit judgment. A random sample of discharge
    summaries without trigger words was reviewed too. It was found
    that 59% of the discharge summaries contained trigger words.
    Based on discharge summary review, 44.8% (327 of 730) of the
    alerted trigger words indicated a possible adverse event. After
    medical record review, the tool detected 131 adverse events. The
    sensitivity and specificity of the screening tool were 69% and
    48%, respectively. The positive predictive value of the tool was
    52%. The study showed that the computerised screening method
    offers researchers and quality managers a means to routinely
    detect adverse events (50).
    The use of Trigger Tools appears to increase the rate of ADE
    detection approximately 50-fold over traditional reporting
    methodologies. This result is based upon a retrospective review of
    patient records (52). This result is supported by another study
    using the Trigger Tool in a neonate ICU. The researchers found
    that the rate of adverse event was substantially higher than
    previously described. Many adverse events resulted in permanent
    harm and the majority of events were classified as preventable.
    Only 8% of the ADEs were identified using traditional voluntary
    reporting methods (54).
    It has been found, that the use of the trigger tool decreased patient
    harm significantly (55)
    Evidence of Clinically use of
    Standards
    The following standard has been used by IHI: “Decrease the
    number of ADEs per 1000 doses by 75 percent within 1 year”
    Indicator category Theme Related PSI: “Medication Errors”.
    Data definitions The total number of ADEs per 1000 doses.
    Numerator Description The total number of ADEs identified in a (defined) sample of
    patient records.
    Denominator Description Total number of medication doses administered to the patient
    records reviewed.
    Data Source Applying Trigger Tool for measuring the frequency of adverse
    drugs events to patient’s records.
    Identifying the institutional
    context
    The assessment of and development of safety related to
    medication is important in general clinical and organisational
    improvement policies.
    Care Setting The indicator applies for medication safety.
    Professionals Responsible for
    heath care
    Doctors and cares.
    Lowest Level of Health Care
    Delivery Addressed
    Individual clinical units or departments.
    SImPatIE WP4 – Catalogue of Patients Safety Indicators
    78
    Allowance for Patient
    Factors
    Not applicable.
    Stratification by Vulnerable
    Populations
    Not applicable.
    Standard of Comparison Comparison over time can be made. No set time frame for
    comparison has been identified.
    Scoring Scoring is made according to the Electronic Trigger Tool chosen
    e.g. (50)